Business Description
InhaleRx Ltd
ISIN : AU0000179475
Description
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.28 | |||||
Equity-to-Asset | 0.42 | |||||
Debt-to-Equity | 0.84 | |||||
Debt-to-EBITDA | -0.39 | |||||
Piotroski F-Score | 3/9 | |||||
Altman Z-Score | -0.09 | |||||
Beneish M-Score | 4.57 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 22.9 | |||||
3-Year EPS without NRI Growth Rate | 22.9 | |||||
3-Year FCF Growth Rate | 22.9 | |||||
3-Year Book Growth Rate | 35.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 0.79 | |||||
9-Day RSI | 5.96 | |||||
14-Day RSI | 14.6 | |||||
6-1 Month Momentum % | 19.05 | |||||
12-1 Month Momentum % | 11.11 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.73 | |||||
Quick Ratio | 1.73 | |||||
Cash Ratio | 0.79 | |||||
Days Sales Outstanding | 467.2 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -32.8 | |||||
Shareholder Yield % | 0.04 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Operating Margin % | -7816 | |||||
Net Margin % | -7708 | |||||
ROE % | -134.44 | |||||
ROA % | -87.37 | |||||
ROIC % | -833.09 | |||||
ROC (Joel Greenblatt) % | -658.26 | |||||
ROCE % | -133.65 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 7 | |||||
EV-to-EBIT | -3.59 | |||||
EV-to-EBITDA | -3.59 | |||||
EV-to-FCF | -2.63 | |||||
Price-to-Net-Current-Asset-Value | 2.8 | |||||
Price-to-Net-Cash | 2.8 | |||||
Earnings Yield (Greenblatt) % | -27.86 | |||||
FCF Yield % | -36.93 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
InhaleRx Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil A$) | |||
EPS (TTM) (A$) | -0.008 | ||
Beta | -0.48 | ||
Volatility % | 123.38 | ||
14-Day RSI | 14.6 | ||
14-Day ATR (A$) | 0.001154 | ||
20-Day SMA (A$) | 0.03665 | ||
12-1 Month Momentum % | 11.11 | ||
52-Week Range (A$) | 0.02 - 0.05 | ||
Shares Outstanding (Mil) | 189.77 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
InhaleRx Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
InhaleRx Ltd Stock Events
Event | Date | Price(A$) | ||
---|---|---|---|---|
No Event Data |
InhaleRx Ltd Frequently Asked Questions
What is InhaleRx Ltd(ASX:IRX)'s stock price today?
When is next earnings date of InhaleRx Ltd(ASX:IRX)?
Does InhaleRx Ltd(ASX:IRX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |